Knight Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acasti Pharma USD 11.06M 3.08M 2024-12
Alaunos Therapeutics USD 1.68M 780K 2024-09
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Avita Medical AUD 14.05M 3.4M 2024-12
Canopy Growth CAD 16.31M 69.8M 2024-12
Cronos Group USD 858.8M 3.22M 2024-12
Dianthus Therapeutics USD 33.67M 280.5M 2024-09
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
IQVIA Holdings USD 1.7B 130M 2024-12
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Moderna USD 1.93B 283M 2024-12
Organigram Holdings 79.26M 7.45M 2024-06
Organon & Co USD 675M 88M 2024-12
Revvity USD 1.16B 66.38M 2024-12
Tectonic Therapeutic USD 159.1M 26.03M 2024-09
Tilray USD 189.7M 15.49M 2024-11
Viatris USD 734.8M 1.14B 2024-12
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12



Knight Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.